391 related articles for article (PubMed ID: 25157821)
1. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
Alexander KA; Flynn R; Lineburg KE; Kuns RD; Teal BE; Olver SD; Lor M; Raffelt NC; Koyama M; Leveque L; Le Texier L; Melino M; Markey KA; Varelias A; Engwerda C; Serody JS; Janela B; Ginhoux F; Clouston AD; Blazar BR; Hill GR; MacDonald KP
J Clin Invest; 2014 Oct; 124(10):4266-80. PubMed ID: 25157821
[TBL] [Abstract][Full Text] [Related]
2. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
[TBL] [Abstract][Full Text] [Related]
3. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
5. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.
Du J; Paz K; Flynn R; Vulic A; Robinson TM; Lineburg KE; Alexander KA; Meng J; Roy S; Panoskaltsis-Mortari A; Loschi M; Hill GR; Serody JS; Maillard I; Miklos D; Koreth J; Cutler CS; Antin JH; Ritz J; MacDonald KP; Schacker TW; Luznik L; Blazar BR
Blood; 2017 May; 129(18):2570-2580. PubMed ID: 28254742
[TBL] [Abstract][Full Text] [Related]
7. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.
MacDonald KP; Palmer JS; Cronau S; Seppanen E; Olver S; Raffelt NC; Kuns R; Pettit AR; Clouston A; Wainwright B; Branstetter D; Smith J; Paxton RJ; Cerretti DP; Bonham L; Hill GR; Hume DA
Blood; 2010 Nov; 116(19):3955-63. PubMed ID: 20682855
[TBL] [Abstract][Full Text] [Related]
8. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice.
Shaikh SN; Willis EF; Dierich M; Xu Y; Stuart SJS; Gobe GC; Bashaw AA; Rawashdeh O; Kim SJ; Vukovic J
J Neuroinflammation; 2023 Dec; 20(1):300. PubMed ID: 38102698
[TBL] [Abstract][Full Text] [Related]
9. SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.
Anthony D; McQualter JL; Bishara M; Lim EX; Yatmaz S; Seow HJ; Hansen M; Thompson M; Hamilton JA; Irving LB; Levy BD; Vlahos R; Anderson GP; Bozinovski S
FASEB J; 2014 Sep; 28(9):3867-77. PubMed ID: 24846388
[TBL] [Abstract][Full Text] [Related]
10. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
[TBL] [Abstract][Full Text] [Related]
11. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
12. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
[TBL] [Abstract][Full Text] [Related]
14. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
Adams RC; Carter-Cusack D; Llanes GT; Hunter CR; Vinnakota JM; Ruitenberg MJ; Vukovic J; Bertolino P; Chand KK; Wixey JA; Nayler SP; Hill GR; Furlan SN; Zeiser R; MacDonald KPA
Blood; 2024 Mar; 143(10):912-929. PubMed ID: 38048572
[TBL] [Abstract][Full Text] [Related]
15. Chronicity following ischaemia-reperfusion injury depends on tubular-macrophage crosstalk involving two tubular cell-derived CSF-1R activators: CSF-1 and IL-34.
Sanchez-Niño MD; Sanz AB; Ortiz A
Nephrol Dial Transplant; 2016 Sep; 31(9):1409-16. PubMed ID: 27190368
[TBL] [Abstract][Full Text] [Related]
16. Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development.
Lee AW; Mao Y; Penninger JM; Yu S
Mol Cell Biol; 2011 Nov; 31(22):4563-81. PubMed ID: 21930791
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response.
Guo L; Lai P; Wang Y; Huang T; Chen X; Geng S; Huang X; Luo C; Wu S; Ling W; Huang L; Du X; Weng J
Int Immunopharmacol; 2020 Jul; 84():106541. PubMed ID: 32402950
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
[TBL] [Abstract][Full Text] [Related]
19. Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.
Jin H; Ni X; Deng R; Song Q; Young J; Cassady K; Zhang M; Forman S; Martin PJ; Liu Q; Zeng D
Blood; 2016 May; 127(18):2249-60. PubMed ID: 26884373
[TBL] [Abstract][Full Text] [Related]
20. Colony stimulating factor-1 dependence of paneth cell development in the mouse small intestine.
Huynh D; Dai XM; Nandi S; Lightowler S; Trivett M; Chan CK; Bertoncello I; Ramsay RG; Stanley ER
Gastroenterology; 2009 Jul; 137(1):136-44, 144.e1-3. PubMed ID: 19303020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
